The 'Problem' With Broadcom's Guidance

Broadcom is viewed as attractive despite a 20% post-earnings pullback, with the key issue being temporary margin compression from product mix rather than structural weakness. Q3 gross margin guidance of 74% is tied to a large $10B XPU shipment, while AI revenue is expected to grow at roughly 2x industry CAGR and now represents nearly half of total revenue. The article frames the selloff as overdone given 62%-66% annual AI growth expectations and intact unit economics.

Analysis

The market is likely still over-penalizing AVGO for a margin headline that is mechanically self-inflicted. If the margin reset is tied to one oversized XPU shipment, the right way to think about the pullback is as a near-term optics issue that compresses multiple on the next print, not as evidence that AI mix is turning destructive to economics. That matters because the market tends to re-rate semis fastest when investors realize gross margin volatility is coming from shipment timing rather than demand elasticity.

The second-order winner is the AI compute ecosystem that depends on custom silicon scale-up rather than generic accelerator pricing power. If Broadcom is still comping at 2x industry AI growth, then hyperscalers are signaling they will keep diversifying away from one-vendor dependency, which is structurally negative for companies relying on narrow GPU bottlenecks but positive for network, interconnect, and custom ASIC suppliers upstream and adjacent. It also suggests the broader AI capex cycle is not peaking; instead, it is broadening from training-centric spend toward deployment and infrastructure buildout.

The main contrarian point is that the current selloff may be the wrong expression of the risk. The real danger is not margin compression itself, but whether investors start extrapolating it into a lower-quality revenue mix and apply a discount to forward earnings power. That risk is most acute over the next 1-2 quarters if gross margins stay suppressed longer than expected, but over 6-12 months the setup still favors multiple recovery if AI revenue continues to accelerate and the mix normalizes.

For the stock, the asymmetry looks better in staged entries than in chasing strength: the pullback creates a window where the market is paying for a temporary accounting effect while underappreciating the durability of AI demand. If management confirms the high-margin core reasserts after the large shipment rolls off, the squeeze higher could be sharp because positioning is likely still skittish after earnings. The key catalyst is not the next revenue beat, but evidence that margin recovery starts one quarter sooner than consensus expects.

Key Decisions for Investors

• Buy AVGO on weakness over the next 1-3 trading sessions; target a 3-6 month rebound as margin optics normalize. Risk/reward favors a recovery trade because the selloff appears tied to shipment timing rather than terminal unit economics.
• Express the view with a call spread in AVGO 3-6 months out rather than outright stock if implied volatility remains elevated. This caps premium paid while capturing a likely post-earnings mean reversion if AI growth stays intact.
• Pair long AVGO / short a higher-multiple AI semiconductor name over 1-2 quarters if you want to isolate the mix-normalization thesis. The pair should benefit if the market rewards durable cash generation over narrative-only AI exposure.
• Do not short AVGO into this pullback unless you have evidence margin pressure is extending beyond the disclosed shipment window. The upside risk is a fast re-rating once investors conclude the gross margin issue is transitory.
• Set a catalyst watch for the next guidance update and next quarterly margin print; if gross margin stabilizes or improves earlier than expected, add to AVGO aggressively. If not, reduce sizing rather than wholesale exit, since the long-term AI revenue trajectory remains the key driver.